NorthWest Biotherapeutics Inc (NWBO)

[ae kusterer]

@BIO99_BIO99
·Feb 24
NCI is excited about DC vaccine potential. Reason they launched 2017 DC vaccine trial in lymphoma in phase 1/2 trial at Mayo Clinic. Results to be released soon. Positive results may result in even faster tissue agnostic approval of NWBO DCVax. Stay tuned. https://beta.clinicaltrials.gov/study/NCT03035331
Show more replies
Bio99
@BIO99_BIO99
·
@BIO99_BIO99
and
@BertanAtac
… probably wanted to know if dendritic cell vaccines also help people with tumors (eg lymphoma) beyond glioblastoma and the solid tumors that NWBO has already targeted. If it is successful, it may allow NWBO to obtain tissue agnostic approval to hematologic …
Bio99
@BIO99_BIO99
·
@BIO99_BIO99
and
@BertanAtac
… malignancies as well. As for Merck’s ability to negotiate with ‘other sponsors’, there is no other game in town beside NWBO that will have approval and a commercialized cost-effective and consistent product nor will there be for years… (or maybe ever)… so, no.
Bio99
@BIO99_BIO99
·
Feb 24
I was playing chess this week. I focused my attention on taking control of the center of the board & nothing else, willingly sacrificing my queen in the early game to gain an advantage. I won. $NWBO has similarly sacrificed short term stock gains for control of the center. Watch!